Radiosynthesis of 3'-deoxy-3'-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivo

Nuclear Medicine and Biology

Volumn 27, Issue 2, 2000, Pages 143-156

  Grierson, John R ^a   Shields, Anthony F ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

3 deoxy 3 fluorothymidine; 18F FLT; DNA synthesis PET imaging Proliferation Fluorine 18; TK 1 Thymidine kinase Thymidine metabolism 11C thymidine

Indexed keywords

3' FLUOROTHYMIDINE; RADIOISOTOPE; THYMIDINE;

ADSORPTION CHROMATOGRAPHY; ARTICLE; CELL METABOLISM; CELL PROLIFERATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NUCLEOTIDE METABOLISM; POSITRON EMISSION TOMOGRAPHY; PURIFICATION; REACTION ANALYSIS; SYNTHESIS;

CELL DIVISION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; DIDEOXYNUCLEOSIDES; FLUORINE RADIOISOTOPES; INDICATORS AND REAGENTS; ISOTOPE LABELING; MOLECULAR CONFORMATION; RADIOPHARMACEUTICALS; SPECTROPHOTOMETRY, ULTRAVIOLET; THYMIDINE; X-RAY DIFFRACTION;

EID: 0034128022     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00104-3     Document Type: Article

References (42)

1. Arn'er E.S., Spasokoukotskaja T., Eriksson S. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem. Biophys. Res. Commun. 188:(2):1992;712-718.
2. Balagopala M.I., Ollapally A.P., Lee H.J. An improved synthesis of azidothymidine. Nucleos. Nucleot. 15:(4):1996;899-906.
3. Baudot P., Jacque M., Robin M. Effect of diaza-polyoxa-macrobicyclic complexing agents on the urinary elimination of lead in lead-poisoned rats. Toxicol. Appl. Pharm. 41:1977;113-118.
4. Beaser S.A., Segal A., Vandan L. The anticoagulant effects in rabbits and man of the intravenous injection of salts of rare earths. J. Clin. Invest. 21:1942;447-454.
5. 11C)thymidine. Proc. Natl. Acad. Sci. USA 69(4), 988-992.
6. Dean J. A. (Ed.) (1985) Lange's Handbook of Chemistry, 13th ed McGraw-Hill, New York.
7. 11C]Thymidine imaging of malignant brain tumors. Cancer Res. 59:(3):1999;615-621.
8. Foulon F., Fixari B., Picq D., Le Perchec D. Catalytic decomposition of alkyl chloroformates by hexabutylguanidinium chloride. Tetrahedron Lett. 38:(19):1997;3387-3390.
9. Fox J.J., Miller N.C. Nucleosides. XVI. Further studies of anhydronucleosides. J. Org. Chem. 28:1963;936-941.
10. 18F]fluoromisonidazole. J. Nucl. Med. 30:1989;343-350.
11. 18F FLT in monkeys (abstract). J. Nucl. Med. 39(5), 190P.
12. 18F]FLT (abstract). J. Nucl. Med. 39(5), 22P.
13. 18F]FLT. J. Labelled Compd. Radiopharm. 42(suppl 1), S525-S526.
14. 18F]FLT (abstract). J. Nucl. Med. 40(5), 83P.
15. 18F]fluoro-3′-deoxy-nucleosides. J. Labelled Compd. Radiopharm. 40:1997;60-62.
16. 18F]FLT vs. [H-3]thymidine in mammalian tumor cells (abstract). J. Nucl. Med. 39(5), 229P.
17. Imamoto T. (1994) Lanthanides in Organic Synthesis: Best Synthetic Methods Series. Academic Press, New York.
18. Kornberg A. (1992) Biosynthesis of DNA precursors. In: DNA Replication, 2nd ed., (Edited by Kornberg A. and Baker T.), pp 53-100, W. H. Freeman and Co., New York.
19. Langen P., Etzold G., Hintsche R., Kowollick G. 3′-Deoxy-3′-fluorothymidine, a new selective inhibitor of DNA synthesis. Acta. Biol. Med. Ger. 23:1969;759-766.
20. 18F]FLT). J. Radioanal. Nucl. Chem. 243(3), 843-846.
21. Mankoff D.A., Shields A.F., Graham M.M., Link J.M., Eary J.F., Krohn K.A. Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies Compartmental model and mathematical analysis . J. Nucl. Med. 39:(6):1998;1043-1055.
22. 11C]thymidine PET imaging studies Validation studies . J. Nucl. Med. 40:(4):1999;614-624.
23. Martiat P., Ferrant A., Labar D., Cogneau M., Bol A., Michel C., Michaux J.L., Sokal G. In vivo measurement of carbon-11 thymidine uptake in non-Hodgkin's lymphoma using positron emission tomography. J. Nucl. Med. 29:(10):1988;1633-1637.
24. Matthes E., Lehmann C., Scholz D., Rosenthal H.-A., Langen P. Phosphorylation, anti-HIV activity and cytotoxicity of 3′-fluorothymidine. Biochem. Biophys. Res. Commun. 153:(2):1988;825-831.
25. Munch-Petersen B., Cloos L., Tyrsted G., Eriksson S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J. Biol. Chem. 266:(14):1991;9032-9038.
26. 18F]fluorothymidine predicts changes in cell proliferation (abstract). J. Nucl. Med. 40(5), 25P.
27. Schinazi R.F., Peck A., Sommadossi J.-P. Substrate specificity of Escherichia coli thymidine phosphorylase for pyrimidine nucleosides with anti-human immunodeficiency virus activity. Biochem. Pharmacol. 44:(2):1992;199-204.
28. Schlyer D. J., Bastos M. and Wolf A. P. (1987) A rapid quantitative separation of fluorine-18 from oxygen-18 water (abstract). J. Nucl. Med. 28, 746P.
29. Sherley J.L., Kelly T.J. Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem. 263:(17):1988;8350-8358.
30. 18F]FLT and FDG in patients with cancer (abstract). J. Nucl. Med. 40(5), 61P.
31. 18F]FLT and positron emission tomography. Nat. Med. 4:(11):1998;1334-1336.
32. 18F]FLT can be used to image cell proliferation (abstract). J. Nucl. Med. 39(5), 228P.
33. 18F]FLT imaging and modeling in dogs (abstract). J. Nucl. Med. 40(5), 25P.
34. Shields A.F., Lim K., Grierson J.R., Link J.M., Krohn K.A. Utilization of labeled thymidine in DNA synthesis Studies for PET . J. Nucl. Med. 31:(3):1990;337-342.
35. Shields A.F., Mankoff D.A., Link J.M., Graham M.M., Eary J.F., Kozawa S.M., Zheng M., Lewellen B., Lewellen T.K., Grierson J.R., Krohn K.A. Carbon-11-thymidine and FDG to measure therapy response. J. Nucl. Med. 39:(10):1998;1757-1762.
36. Sugimura H., Osumi K., Kodaka Y. and Sujino K. (1994) Stereoselective synthesis of 2′-deoxy-β-D-threo-pentofuranosyl nucleosides by the NBS-promoted coupling reaction of thioglycosides with silylated heterocyclic bases. J. Org. Chem. 59(25), 7653-7660.
37. Sundseth R., Joyner S.S., Moore J.T., Dornsife R.E., Dev I.K. The anti-human immunodeficiency virus agent 3′-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid cells. Antimicrob. Agents Chemother. 40:(2):1996;331-335.
38. 3-protecting group. Tetrahedron Lett. 32(16), 1905-1908.
39. 11C-thymidine activity in human head and neck tumours using positron emission tomography (PET). Acta Oncol. 31:(5):1992;539-543.
40. 18F-radiolabeling, as a tracer for the non-invasive monitoring of the biodistribution of drugs against AIDS. J. Fluorine Chem. 55:1991;283-289.
41. Yau E.K., Coward J.K. Filter chromatography. Aldrichim. Acta. 21:(4):1988;106-107.
42. Young H., Brock C., Wells P., Price P. Monitoring response to treatment in the development of anti-cancer drugs using positron emission tomography. Drug Inform. J. 33:1999;237.